Patient Education
Share your love
iOpeners: Joseph Coney, MD, champions ophthalmic advocacy with Nicole Bajic, MD | Ophthalmology Times
In this latest episode of “iOpeners” from Ophthalmology Times, host Nicole Bajic, MD, comprehensive ophthalmologist at the Cole Eye Institute, Cleveland Clinic, sits down with Joseph Coney, MD, a vitreoretinal surgeon at Retina Associates of Cleveland. Coney also serves on…
AAO 2025: Margaret A. Chang, MD, MS, highlights OTX-TKI’s impact on retinal fluid | Ophthalmology Times
Margaret A. Chang, MD, MS, presented updates from the HELIOS Phase 1 trial of OTX-TKI, a sustained-release formulation of the tyrosine kinase inhibitor, axitinib, for the treatment of diabetic retinopathy (DR), at the American Academy of Ophthalmology 2025 annual meeting,…
Throwback Series: Learning when to intervene surgically in glaucoma | Ophthalmology Times
In celebration of Ophthalmology Times’ 50th anniversary, leaders in ophthalmology revisit a memorable “throwback” case from earlier in their careers. In this special series, they reflect on how evolving knowledge, techniques, and technologies have transformed the way such cases are managed…
Systemic chemotherapy reduces mortality in retinoblastoma: 30-year analysis from Iran | Ophthalmology Times
(Image Credit: AdobeStock/Sherry Young) A new study in the International Journal of Retina and Vitreous reported that use of systemic chemotherapy as a mainstay of treatment for retinoblastoma results in significant decreases in mortality and morbidity. Adding targeted chemotherapy reduced…
The mechanics of presbyopia: From muscle movement to functional vision | Ophthalmology Times
(Image Credit: AdobeStock) Presbyopia-correcting eye drops share a common mechanism: They are miotic agents designed to create a smaller pupil. The power of the pupil to extend depth of focus is impressive, as observed in patients with smaller pupils who…
Subretinal drusenoid deposits in Black and Hispanic patients with AMD | Ophthalmology Times
(Image Credit: Adobestock/Alessandro Grandini) Researchers from New York Eye and Ear Infirmary of Mount Sinai, New York, reported that subretinal drusenoid deposits (SDDs) in patients with age-related macular degeneration (AMD) who are Black or Hispanic may indicate that they are…
AAO 2025: Early optogenetic therapy shows promise for patients with inherited retinal diseases | Ophthalmology Times
Stephen Tsang, MD, PhD, professor at Columbia University and attending physician at NewYork-Presbyterian Hospital, shared encouraging early findings on the use of optogenetic therapy for patients with retinitis pigmentosa and Stargardt disease. According to Tsang, a single optogenetic treatment has…
Throwback Series: Identifying and treating neovascular lesions in pregnancy | Ophthalmology Times
In celebration of Ophthalmology Times’ 50th anniversary, we invited leaders in ophthalmology to revisit a memorable “throwback” case from earlier in their careers. In this special series, they reflect on how evolving knowledge, techniques, and technologies have transformed the way…
Q&A: Insights from Rajesh K. Rajpal, MD, on an incision-free keratoconus therapy | Ophthalmology Times
A novel topical, incision-free therapy is now approved to help ophthalmologists slow or halt the progression of keratoconus. (Image credit: AdobeStock/Alessandro Grandini) Glaukos recently received FDA approval for its topical, incision-free therapy for keratoconus (Epioxa) that does not require removal…
Rethinking punctal occlusion as an option for allergic conjunctivitis | Ophthalmology Times
(Image Credit: AdobeStock) The intracanalicular dexamethasone ophthalmic insert (Dextenza; Ocular Therapeutix) incorporates 0.4 mg of dexamethasone into the hydrogel matrix to treat postoperative inflammation and pain following ocular surgery. It is also approved for the treatment of ocular itching associated…